Compare Wayfair Inc (W) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Wayfair Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Wayfair Inc trades at $84.8 (market cap $11.58B), while State Street SPDR S&P Biotech ETF trades at $154.49. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Wayfair Inc nearer its low. Which is the better fit depends on your goals.
| W | XBI | |
|---|---|---|
Market Cap | $11.58B | — |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $119.05 | $164.28 |
52-Week Low | $56.42 | $85.16 |
Enterprise Value | $14.16B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Wayfair Inc
Wayfair is a global leader in home goods, operating a massive digital marketplace that connects millions of consumers with thousands of suppliers. It utilizes an asset-light, inventory-light model combined with a proprietary logistics network (CastleGate) and an accelerating brick-and-mortar presence to deliver an end-to-end shopping experience for everything from decor to full home renovations.
Read more on W →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
